SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
TELK -- Telik, Inc.
An SI Board Since October 2000
Posts SubjectMarks Bans Symbol
887 37 0 TELK
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
762It looks like a 2-way play: if T hits, they make gobs of money; if it bombs, theDewDiligence_on_SI-12/13/2006
761After having received "permission" to buy more shares, the Black BearsIcebrg-12/13/2006
760Item 1.01 Entry into a Material Definitive Agreement. On December 11, 2006, TelIcebrg-12/13/2006
759Telik Announces Positive Data Demonstrating that TELINTRA(TM) Enhances Productionigel bates-12/9/2006
758I sold yesterday except for a tiny inconsequential..based on absolutely no new izeta1961-12/8/2006
757I may have already gurgitated this piece from Merrill when it came out last monttom pope-12/4/2006
756Thanks sales..very much..what I'm most struck in these reports is they give zeta1961-12/3/2006
755>So if management insisted on going forward with 4 & 5, that would be a sformer_pgs-12/3/2006
754Thanks, Sales, Wow, only a buck a share for Telintra. Giving it less chance oftuck-12/3/2006
753lehman - - jim birchenough 1 Investment Thesis We believe that significant downsoftware salesperson-12/3/2006
752well, you asked. here's one negative view, via my fidelity account, with anosoftware salesperson-12/3/2006
751Tuck, thanks for bringing this valuation conversation..here's an ASH poster zeta1961-12/3/2006
750FWIW, I'm seeing prevalence numbers for MDS of 150,000 (per Novartis and othtuck-12/3/2006
749All three fail, Telcyta is dead, you're saying. Seems reasonable. So if matuck-12/3/2006
748>Suppose doomsday scenario occurs and ASSIST 1 ,2, & 3 all fail. What remformer_pgs-12/3/2006
747Suppose doomsday scenario occurs and ASSIST 1 ,2, & 3 all fail. What remaituck-12/2/2006
746Telintra ASH abstract..rat study.. [1161] Telintra (TLK199) Enhances Granulocytzeta1961-11/29/2006
745<i>Just a headline</i> News 17.77 -0.93 Telik Cut To Underweight FLJM-11/15/2006
744We have got some somewhat confusing changes in ownership. - On the Nasdaq siteIcebrg-11/14/2006
743IBM Unleashes New Breed of Hybrid Supercomputers With System Cluster 1350 Top ReIcebrg-11/7/2006
742Thanks PGS..here's the 2002 ASCO abstract on the 1000mg dose..this reminds mzeta1961-10/17/2006
741NSCLC P2s: The first NSCLC phase II they ran was with 1000 mg / m2 once every 3former_pgs-10/17/2006
740<i>Least Likely to Hit Primary Endpoint: ASSIST-2 In the two phase II trizeta1961-10/17/2006
739Some recent thoughts from PGS on the Assist trials in his biotech blog Biotech+.Icebrg-10/17/2006
738Thanks for the analysis of the analysts. Interesting take on what audience theytechnetium-10/7/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News